{
    "nctId": "NCT05409222",
    "briefTitle": "Study of Quality of Life Post Salpingo-oophorectomy in BRCA1/2 & PALB2 Mutation Carriers (BRCA-HRT)",
    "officialTitle": "Study of Quality of Life Post Preventive Salpingo-oophorectomy in Healthy BRCA1/2 and PALB2 Mutation Carriers",
    "overallStatus": "UNKNOWN",
    "conditions": "Hereditary Breast and Ovarian Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 45,
    "primaryOutcomeMeasure": "To compare the scale MenCav of quality of life in premenopausal carriers opting and rejecting hormone replacement therapy post salpingo-oophorectomy",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Age between 30 and 49 years\n2. Being a member of a family with a history of hereditary breast and ovarian cancer, with a cancer risk\\> 10% or being a carrier of the BRCA1 / 2 or PALB2 mutation.\n\nExclusion Criteria:\n\n1. Personal history of oophorectomy for benign or malignant ovarian pathology.\n2. Personal history of breast cancer.",
    "sex": "FEMALE",
    "minimumAge": "30 Years",
    "stdAges": "ADULT"
}